Samsung Bioepis Goes After Lucentis With 40% Cheaper Byooviz Launch In US

Delivers Global First With Ranibizumab Biosimilar Launch Through Partner Biogen

Eye closeup dollar symbol
The first ophthalmic biosimilar offers significant savings over Lucentis • Source: Shutterstock

More from Biosimilars

More from Products